Market Cap 16.27M
Revenue (ttm) 219.64M
Net Income (ttm) -666.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -303.54%
Debt to Equity Ratio 0.00
Volume 29,751,400
Avg Vol 4,747,332
Day's Range N/A - N/A
Shares Out 26.83M
Stochastic %K 5%
Beta 1.19
Analysts Strong Buy
Price Target $12.60

Company Profile

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier condi...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 938 6300
Address:
349 Oyster Point Boulevard, South San Francisco, United States
Latest News on ME
No data available.